Retatrutide is a new medication in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimately contributes to significant slimming. While studies are still